Skip Navigation

Protecting Health, Saving Lives—Millions at a Time

COVID-19 | School of Public Health Expert Insights

COVID-19

School of Public Health Expert Insights

News Releases


October 28, 2020

New Johns Hopkins Center for Research on COVID-19 Immunity

Researchers at the Bloomberg School and School of Medicine have been jointly awarded a major grant from the National Cancer Institute to set up a center for research on the human serological immune response to COVID-19.

October 21, 2020

Americans' Responses to COVID-19 Stay-Home Orders Differed According to Population Density

Americans strongly reduced their visits to grocery stores, pharmacies, and transit stations following stay-at-home orders from mayors and governors earlier this year, but did not reduce their visits to parks and beaches.

October 19, 2020

Patients Who Had More Severe COVID-19 May Be the Best Donors for Convalescent Plasma Therapy

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease.

October 15,  2020

Survey: More U.S. Adults Want the Government to Have a Bigger Role in Improving Peoples' Lives Than Before the Pandemic

The share of U.S. adults who support an active government role in society increased by more than 40 percent during the initial pandemic response.

October 2, 2020

Study Highlights Shortcomings in Telemedicine Despite Large Increases in Remote Consults During COVID-19 Pandemic

Despite increased use of telemedicine during the COVID-19 pandemic, Americans have had significantly fewer consultations with primary care doctors and markedly fewer assessments of common cardiac risk factors.

September 10, 2020

Covid-19 Study Links Strict Social Distancing to Much Lower Chance of Infection

Using public transportation, visiting a place of worship, or otherwise traveling from the home is associated with a significantly higher likelihood of testing positive with the coronavirus SARS-CoV-2.

July 30, 2020

Johns Hopkins Receives $35 Million in Funding from Department of Defense for COVID-19 Blood Plasma Trials

Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) JPEO-CBRND, on behalf of the Defense Health Agency, for two nationwide clinical trials.

July 8, 2020

COVID-19 Cases and Deaths in Federal and State Prisons Significantly Higher Than in U.S. Population

A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population.

June 18, 2020

Study: Urban Density Not Linked to Higher Coronavirus Infection Rates—and Is Linked to Lower COVID-19 Death Rates

A new study suggests that denser places, assumed by many to be more conducive to the spread of the coronavirus that causes COVID-19, are not linked to higher infection rates.

June 15, 2020

COVID-19 Hospitalizations Could Mean Significant Out-of-Pocket Medical Costs for Many Americans

Many Americans could face high out-of-pocket medical costs for COVID-19 hospitalizations despite the fact that many insurers have waived their cost-sharing requirements.

June 9, 2020

Majority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings, Study Finds

Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a study from researchers at JHSPH.

June 3, 2020

Survey Finds Large Increase in Psychological Distress Reported Among U.S. Adults During the COVID-19 Pandemic

A new survey conducted by researchers at JHSPH during the COVID-19 pandemic found a more-than-threefold increase in the percentage of U.S. adults who reported symptoms of psychological distress—from 3.9 percent in 2018 to 13.6 percent in April 2020.

May 11, 2020

Johns Hopkins and Bloomberg Philanthropies, with New York State, Launch Online Course to Train Army of Contact Tracers to Slow Spread of COVID-19

Johns Hopkins Bloomberg School of Public Health, with Bloomberg Philanthropies, today launched a free online course to help train a new cadre of contact tracers to reach and assist people exposed to the virus that causes COVID-19.

April 9, 2020

Experts Warn High Rates of Positive COVID-19 Tests Show U.S. Not Ready to Relax Restrictions; Also Note Signs in Africa of “Silent” Spread of Disease

The high percentage of positive results from COVID-19 tests indicates the United States has “not yet found the edges of the outbreak” and is not ready to transition from a stay-at-home strategy to a cautious return to normalcy.

March 27, 2020

Bloomberg Philanthropies, State of Maryland to Fund Johns Hopkins University-led COVID-19 Treatment Research

Bloomberg Philanthropies, Maryland Governor Larry Hogan and Johns Hopkins University announced today a joint effort to fund research into the potential therapeutic uses of COVID-19 convalescent plasma, led by infectious disease expert Arturo Casadevall.

March 13, 2020

Infectious Disease Experts Recommend Using Antibodies from COVID-19 Survivors as Stopgap Measure to Treat Patients and Protect Healthcare Workers

Countries fighting outbreaks of coronavirus should consider using the antibodies of people who have recovered from infection to treat cases and provide short-term immunity to critical health care workers, argue two infectious disease experts at JHSPH.

March 9, 2020

New Study on COVID-19 Estimates 5.1 Days for Incubation Period

An analysis of publicly available data on infections from the new coronavirus, SARS-CoV-2, that causes the respiratory illness COVID-19 yielded an estimate of 5.1 days for the median disease incubation period, according to a new JHSPH-led study.

October 24, 2019

Inaugural Global Health Security Index Finds Significant Gaps in Preparedness for Epidemics and Pandemics

A new Global Health Security Index released today suggests that not a single country in the world is fully prepared to handle an epidemic or pandemic.